Sumit Sangwan's one-year ban lifted by NADA

Image
ANI Others
Last Updated : Mar 02 2020 | 9:40 PM IST

Indian boxer Sumit Sangwan, who was to serve a one-year ban for consuming a prohibited substance, has been cleared by National Anti-Doping Agency (NADA) after the athlete proved he took the medicine unintentionally.

The former Asian Games silver medallist's doping test showed the presence of Acetazolamide and was banned for one year on December 26 last year.

The boxer is now also eligible to take part in the upcoming 2020 Tokyo Olympics. After the ban was lifted, Sangwan admitted that he faced hard times during that period but his family support helped him to tackle the situation.

"I have faced many things in these circumstances but I am taking this in a positive way because these things happened and I tackled them. I witnessed some hard times but family supported me and with the help of that I managed to face all those things," Sangwan told ANI.

"Even during this time, I used to travel to different places to practice because I knew I have not done anything wrong and will get through this thing," he added.

Earlier on December 26, NADA had taken to Twitter to announce its decision.

"Indian Boxer Sumit Sangwan had tested positive for the presence of Acetazolamide substance which comes under the category of 'Diuretics and Masking' agents. His sample was collected on 10th October 2019 while he was participating in the Elite Men Boxing Championship, 2019. (Contd.)," NADA India had tweeted.

"Today the Anti-Doping Disciplinary Panel has rendered him ineligible for a period of one year under Article 10.5.1. In the absence of any provisional suspension, his suspension ordered by the Panel shall commence from today, i.e. 26th December 2019. (Contd.)," it had said in another tweet.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 02 2020 | 9:33 PM IST

Next Story